These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 17362923

  • 21. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
    Li P, Fukuhara M, Diz DI, Ferrario CM, Brosnihan KB.
    J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953
    [Abstract] [Full Text] [Related]

  • 22. Thromboxane prostanoid receptor activation impairs endothelial nitric oxide-dependent vasorelaxations: the role of Rho kinase.
    Liu CQ, Leung FP, Wong SL, Wong WT, Lau CW, Lu L, Yao X, Yao T, Huang Y.
    Biochem Pharmacol; 2009 Aug 15; 78(4):374-81. PubMed ID: 19409373
    [Abstract] [Full Text] [Related]

  • 23. Regulation of activator protein-1 by 8-iso-prostaglandin E2 in a thromboxane A2 receptor-dependent and -independent manner.
    Weber TJ, Markillie LM.
    Mol Pharmacol; 2003 May 15; 63(5):1075-81. PubMed ID: 12695536
    [Abstract] [Full Text] [Related]

  • 24. U-46619-induced potentiation of noradrenergic constriction in the human saphenous vein: antagonism by thromboxane receptor blockade.
    Vila JM, Martínez-León JB, Medina P, Segarra G, Ballester RM, Otero E, Lluch S.
    Cardiovasc Res; 2001 Dec 15; 52(3):462-7. PubMed ID: 11738063
    [Abstract] [Full Text] [Related]

  • 25. Interleukin-1beta-induced hyperresponsiveness to [Sar9,Met(O2)11]substance P in isolated human bronchi.
    Barchasz E, Naline E, Molimard M, Moreau J, Georges O, Emonds-Alt X, Advenier C.
    Eur J Pharmacol; 1999 Aug 20; 379(1):87-95. PubMed ID: 10499376
    [Abstract] [Full Text] [Related]

  • 26. Pharmacological evidence for thromboxane receptor heterogeneity--implications for the eye.
    Krauss AH, Woodward DF, Burk RM, Gac TS, Gibson LL, Protzman CE, Abbass F, Marshall K, Senior J.
    J Ocul Pharmacol Ther; 1997 Aug 20; 13(4):303-12. PubMed ID: 9261766
    [Abstract] [Full Text] [Related]

  • 27. Effects of the dual TP receptor antagonist and thromboxane synthase inhibitor EV-077 on human endothelial and vascular smooth muscle cells.
    Petri MH, Tellier C, Michiels C, Ellertsen I, Dogné JM, Bäck M.
    Biochem Biophys Res Commun; 2013 Nov 15; 441(2):393-8. PubMed ID: 24161392
    [Abstract] [Full Text] [Related]

  • 28. Regulation of extracellular signal-regulated kinase cascades by alpha- and beta-isoforms of the human thromboxane A(2) receptor.
    Miggin SM, Kinsella BT.
    Mol Pharmacol; 2002 Apr 15; 61(4):817-31. PubMed ID: 11901221
    [Abstract] [Full Text] [Related]

  • 29. Human internal mammary artery contraction by isoprostaglandin f(2alpha) type-III [8-iso-prostaglandin F(2alpha)].
    Cracowski JL, Stanke-Labesque F, Devillier P, Chavanon O, Hunt M, Souvignet C, Bessard G.
    Eur J Pharmacol; 2000 May 26; 397(1):161-8. PubMed ID: 10844110
    [Abstract] [Full Text] [Related]

  • 30. Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552.
    Harris DN, Michel IM, Goldenberg HJ, Hartl KS, Allen GT, Steinbacher TE, Schumacher WA, Han WC, Hall SE, Floyd DM.
    J Pharmacol Exp Ther; 1992 Apr 26; 261(1):131-7. PubMed ID: 1532833
    [Abstract] [Full Text] [Related]

  • 31. Thromboxane receptors in smooth muscle promote hypertension, vascular remodeling, and sudden death.
    Sparks MA, Makhanova NA, Griffiths RC, Snouwaert JN, Koller BH, Coffman TM.
    Hypertension; 2013 Jan 26; 61(1):166-73. PubMed ID: 23150508
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Human umbilical vein vasoconstriction induced by epinephrine acting on alpha1B-adrenoceptor subtype.
    Errasti AE, Werneck de Avellar MC, Daray FM, Tramontano J, Luciani LI, Lina Bard MJ, Maróstica E, Rothlin RP.
    Am J Obstet Gynecol; 2003 Nov 26; 189(5):1472-80. PubMed ID: 14634588
    [Abstract] [Full Text] [Related]

  • 34. Enhanced contractility of renal afferent arterioles from angiotensin-infused rabbits: roles of oxidative stress, thromboxane prostanoid receptors, and endothelium.
    Wang D, Chabrashvili T, Wilcox CS.
    Circ Res; 2004 Jun 11; 94(11):1436-42. PubMed ID: 15117817
    [Abstract] [Full Text] [Related]

  • 35. Characterization of the thromboxane (TP-) receptor subtype involved in proliferation in cultured vascular smooth muscle cells of rat.
    Ko FN, Yu SM, Kang YF, Teng CM.
    Br J Pharmacol; 1995 Sep 11; 116(2):1801-8. PubMed ID: 8528563
    [Abstract] [Full Text] [Related]

  • 36. Mechanisms of the prostaglandin F2alpha-induced rise in [Ca2+]i in rat intrapulmonary arteries.
    Snetkov VA, Knock GA, Baxter L, Thomas GD, Ward JP, Aaronson PI.
    J Physiol; 2006 Feb 15; 571(Pt 1):147-63. PubMed ID: 16357015
    [Abstract] [Full Text] [Related]

  • 37. A new family of thromboxane receptor antagonists with secondary thromboxane synthase inhibition.
    Pace-Asciak CR, Reynaud D, Demin P, Aslam R, Sun A.
    J Pharmacol Exp Ther; 2002 May 15; 301(2):618-24. PubMed ID: 11961065
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Prostaglandin I2 mediates contraction and relaxation of vascular smooth muscle.
    Williams SP, Dorn GW, Rapoport RM.
    Am J Physiol; 1994 Aug 15; 267(2 Pt 2):H796-803. PubMed ID: 8067435
    [Abstract] [Full Text] [Related]

  • 40. Pharmacological characterization of thromboxane and prostanoid receptors in human isolated urinary bladder.
    Palea S, Toson G, Pietra C, Trist DG, Artibani W, Romano O, Corsi M.
    Br J Pharmacol; 1998 Jul 15; 124(5):865-72. PubMed ID: 9692770
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.